[Some considerations on the postphlebitic syndrome].
After a brief description of the aetiopathogenetic aspects of the phlebitic and postphlebitic syndrome, medical and surgical therapies for this syndrome are reviewed. A derivative of the phenybutazone group (Febutol) is then discussed and its considerable effectiveness emphasized.
D000925:Anticoagulants / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004322:Drainage; D006439:Hemodynamics; D006801:Humans; D010653:Phenylbutazone / Q000627:therapeutic use; D010689:Phlebitis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D012431:Rutin / Q000627:therapeutic use; D014689:Venous Insufficiency / Q000209:etiology
D000925:Anticoagulants; D004232:Diuretics; D012431:Rutin; D010653:Phenylbutazone
Alcune considerazioni sulla sindrome postflebitica